Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Free Cash Flow: 2010-2024

Historic Free Cash Flow for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$538,411.

  • China Pharma Holdings' Free Cash Flow fell 529.70% to -$237,598 in Q3 2025 from the same period last year, while for Sep 2025 it was $122,692, marking a year-over-year increase of 116.98%. This contributed to the annual value of -$538,411 for FY2024, which is 24.30% up from last year.
  • Per China Pharma Holdings' latest filing, its Free Cash Flow stood at -$538,411 for FY2024, which was up 24.30% from -$711,203 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Free Cash Flow ranged from a high of -$538,411 in FY2024 and a low of -$909,567 during FY2020.
  • Over the past 3 years, China Pharma Holdings' median Free Cash Flow value was -$711,203 (recorded in 2023), while the average stood at -$687,041.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 292.58% in 2020, then increased by 24.37% in 2021.
  • Yearly analysis of 5 years shows China Pharma Holdings' Free Cash Flow stood at -$909,567 in 2020, then rose by 24.37% to -$687,893 in 2021, then dropped by 17.97% to -$811,509 in 2022, then climbed by 12.36% to -$711,203 in 2023, then grew by 24.30% to -$538,411 in 2024.